It started with a belief

For 40 years, we have imagined a healthier, better world and we continue to find new ways to help people with life-changing medical conditions.

READ OUR ANNUAL REPORT

News & Stories

Our latest news from Canada and around the world

08/22/2024

Press release

Canadian Study Reveals New Approach to Managing Bleeding Risks in Patients on FXa Inhibitors with the prophylactic use of octaplex® During Emergency Surgery

05/22/2024

Press release

Wilate® is now approved in Canada for Prophylaxis in Von Willebrand Disease

02/14/2024

Press release

Octaplas LG® Powder for solution for infusion: Making a Vital Contribution to the Health of Canadian Soldiers

07/19/2022

Press release

INESSS recommends the addition of Fibryga® to the blood product list of Québec

SHOW ALL NEWS

Patient Engagement

Octapharma plays a vital role in our community

We support projects that enhance the quality of life of Canadians living with rare disorders.

Learn how we engage with patients

Careers in Canada

Explore a new world of opportunities

When you choose to gives us your talent, you become a member of our family. From researching and developing therapies to helping people live near normal lives, your talent can help us achieve more, working together and learning from each other.

Working with Octapharma

It started with a belief

Our latest news from Canada and around the world

Canadian Study Reveals New Approach to Managing Bleeding Risks in Patients on FXa Inhibitors with the prophylactic use of octaplex® During Emergency Surgery

Wilate® is now approved in Canada for Prophylaxis in Von Willebrand Disease

Octaplas LG® Powder for solution for infusion: Making a Vital Contribution to the Health of Canadian Soldiers

INESSS recommends the addition of Fibryga® to the blood product list of Québec

Octapharma plays a vital role in our community

Explore a new world of opportunities

About us

Plasma

Therapies

Working with us

News